Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer

The incidence of lung cancer is increasing in China, in contrast to trends in Western countries, due to the increasing numbers of smokers and high levels of air pollution. Non-small-cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for approximately 85% of lung cancers. Bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hui, Sun, Si, Hu, Xingjiang, Xia, Jinjing, Wang, Jialei, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699152/
https://www.ncbi.nlm.nih.gov/pubmed/31616158
http://dx.doi.org/10.2147/OTT.S185115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699152/
https://www.ncbi.nlm.nih.gov/pubmed/31616158
http://dx.doi.org/10.2147/OTT.S185115

Ejemplares similares